With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

I was pleasantly surprised to see gradual weight loss as well.” What are you waiting for? It’s time to achieve your wellness ...

AstraZeneca PLC shed GBP15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company (UK:AZN) said its lead product ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

Spending on GLP-1s in Medicaid has followed broader industry trends, growing significantly over the past several years, according to a ...

“When we compare bariatric surgery to bariatric ... and 123 had it combined with GLP-1 RAs, specifically liraglutide. They ...